|
|
|
|
PegIntron Maintenance Therapy in Cirrhotic (METAVIR F4) HCV Patients Who Failed to Respond to Interferon/Ribavirin (IR) Therapy: Final Results of the EPIC3 Cirrhosis Maintenance Trial
|
|
|
Reported by Jules Levin
J Bruix, T Poynard, M Colombo, E Schiff, J Reichen, K Burak,
EJL Heathcote, T Berg, J-L Poo, C Brandao Mello, R Guenther,
C Niederau, R Terg, N Boparai, J Harvey, LH Griffel, M Burroughs, CA Brass, JK Albrecht for the EPIC3 Study Group
44th Annual Meeting of the European Association for the Study of the Liver
Friday, April 24, 2009
Copenhagen, Denmark
|
|
|
|
|
|
|